Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response

The ways of pharmacological correction of cardiovascular complications in the syndrome of the systemic inflammatory response (SIRS) are not fully developed. Goal: Determination of statins‘ new pharmacological effects and its combination with endothelioprotectors in the SIRS correction. Materals and Methods: In experiments on mice, rats and rabbits, the antiinflammatory, cardioprotective and endothelioprotective effects of statins and endothelioprotectors were explored. The modeling of endotoxin-induced endothelial dysfunction (EIED) was created by infecting rats with Staphylococcus aureus (strain 13407), subcutaneously (60 billion microbial bodies). To determine the activity of the inflammatory process, the indices of the C-reactive protein used. The involvement of the cytokine link of inflammation was assessed according to the plasma levels of TNF-α and IL-6. Modeling of L-NAME-induced pathology and further evaluation of endothelial and endothelium-independent vascular reactions were carried through according to a standard protoco

Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction

The concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor with simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of endotoxin-induced disorder modeling by Staphylococcus aureus (strain 13407) injection under the skin – 60 billions of microbial bodies – exhibits an endothelium- and cardioprotective action which is evident as endothelial dysfunction factor (EDF) increase prevention, adrenoreactivity, maintenance of myocardial reserve, and normalization of biochemical markers (total NO, expression of eNOS, C-reactive protein, IL-6, tumor necrosis factor

Lipid distress-syndrome and prospects of its correction by statines

Endothelial dysfunction in peritonitis: The formed concept of lipid distress syndrome (LDS) allows us to develop a working hypothesis on the key role of endothelial dysfunction in the aggressive development of atherosclerosis. The role of vascular endothelium in atherosclerosis: The process of NO production from L-arginine through eNOS involving tetrahydrobiopterin (BH4) is discussed. With the degradation of BH4 along the free radical path, an "eNOS uncouplation" (uncoupled eNOS). The clinical role of statins: Statins manifests itself by inhibiting the enzyme 3-hydroxy- 3-methylglutaryl-coenzyme A (HMG-CoA reductase). Many large, randomized clinical trials have shown that lipid-lowering strategies that include statins have an anti-atherogenic potentia

ОПТИЧЕСКИЕ СВОЙСТВА ТОНКИХ ПЛЕНОК ZnO+10 % ITO НА ПОДЛОЖКАХ АНОДНОГО ОКСИДА АЛЮМИНИЯ

ZnO thin films of zinc oxide doped with 10 % ITO (indium tin oxide) on anodic aluminum oxide substrates are formed in vacuum during high-frequency repetitively pulsed laser deposition. The morphology of films on porous and non-porous surfaces of substrates was studied by atomic force microscopy. The optical properties of the films in the visible, near, and middle IR regions of the electromagnetic radiation spectrum, the Raman spectra, and also the features of the photoluminescence characteristics have been experimentally investigated. Zinc oxide films can be used in optoelectronic transducers, as luminescent material, in the form of transparent electrodes, sensitive layers of gas and biological sensors, catalysts, X-ray and gamma-radiation detectors.Тонкие пленки оксида цинка ZnO, легированные 10 % ITO (оксидом индия-олова), на подложках из анодного оксида алюминия сформированы в вакууме при высокочастотном импульснопериодическом лазерном осаждении. Методом атомно-силовой микроскопии изучены морфологии пленок на пористой и беспористой поверхностях подложек. Экспериментально исследованы оптические свойства пленок в видимой, ближней и средней инфракрасных областях спектра электромагнитного излучения, спектры комбинационного рассеяния, а также особенности фотолюминесцентных характеристик. Пленки оксида цинка могут быть использованы в оптоэлектронных преобразователях как люминесцентный материал, в виде прозрачных электродов, чувствительных слоев газовых и биологических сенсоров, катализаторов, детекторов рентгеновского и гамма-излучений

Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction

The concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor with simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of endotoxin-induced disorder modeling by Staphylococcus aureus (strain 13407) injection under the skin – 60 billions of microbial bodies – exhibits an endothelium- and cardioprotective action which is evident as endothelial dysfunction factor (EDF) increase prevention, adrenoreactivity, maintenance of myocardial reserve, and normalization of biochemical markers (total NO, expression of eNOS, C-reactive protein, IL-6, tumor necrosis factor

Lipid distress-syndrome and prospects of its correction by statines

Endothelial dysfunction in peritonitis: The formed concept of lipid distress syndrome (LDS) allows us to develop a working hypothesis on the key role of endothelial dysfunction in the aggressive development of atherosclerosis. The role of vascular endothelium in atherosclerosis: The process of NO production from L-arginine through eNOS involving tetrahydrobiopterin (BH4) is discussed. With the degradation of BH4 along the free radical path, an "eNOS uncouplation" (uncoupled eNOS). The clinical role of statins: Statins manifests itself by inhibiting the enzyme 3-hydroxy- 3-methylglutaryl-coenzyme A (HMG-CoA reductase). Many large, randomized clinical trials have shown that lipid-lowering strategies that include statins have an anti-atherogenic potentia

Interaction between agriculture and nature conservation in Poland

SIGLEGBUnited Kingdo

Optical properties of thin films ZNO+10 % ITO on the substrate of anodic aluminum oxide

ZnO thin films of zinc oxide doped with 10 % ITO (indium tin oxide) on anodic aluminum oxide substrates are formed in vacuum during high-frequency repetitively pulsed laser deposition. The morphology of films on porous and non-porous surfaces of substrates was studied by atomic force microscopy. The optical properties of the films in the visible, near, and middle IR regions of the electromagnetic radiation spectrum, the Raman spectra, and also the features of the photoluminescence characteristics have been experimentally investigated. Zinc oxide films can be used in optoelectronic transducers, as luminescent material, in the form of transparent electrodes, sensitive layers of gas and biological sensors, catalysts, X-ray and gamma-radiation detectors